NASDAQ:LUXA Lux Health Tech Acquisition (LUXA) Stock Price, News & Analysis → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free LUXA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$10.04▼$10.0450-Day Range$10.00▼$10.0452-Week Range$9.75▼$10.12Volume1 shsAverage Volume136,765 shsMarket Capitalization$432.98 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Lux Health Tech Acquisition alerts: Email Address Ad Awesomely, LLCAutomatic Income (from home)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. Just click here now to watch my presentation for free. About Lux Health Tech Acquisition Stock (NASDAQ:LUXA)Lux Health Tech Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the healthcare and technology industries. The company was incorporated in 2020 and is based in New York, New York.Read More Ad Awesomely, LLCAutomatic Income (from home)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. Just click here now to watch my presentation for free. LUXA Stock News HeadlinesMarch 31, 2024 | benzinga.comPeter Hebert's Net WorthMarch 7, 2024 | axios.comTampa General Hospital balances tech tools and traditional acquisitionsMay 3, 2024 | Altimetry (Ad)Urgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.February 23, 2024 | msn.comMD Anderson acquires cell therapy safety technology from Bellicum PharmaceuticalsNovember 20, 2023 | bizjournals.comLux Living drops plan to build apartments at historic St. Louis siteNovember 16, 2023 | yahoo.comModern Luxury Media Launches M/Lux Streaming PlatformNovember 10, 2023 | news.yahoo.comGrand Lux Cafe in Chicago to close its doors for goodOctober 26, 2023 | bizjournals.comHer Campus Media bets on Gen Z influencer platform for 6th acquisitionMay 3, 2024 | Altimetry (Ad)Urgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.September 16, 2023 | axios.comDigital health deal value hit a new low in Q2July 13, 2023 | bloomberg.comHCL Tech to Buy German Car Engineering Firm for $280 MillionJuly 13, 2023 | msn.comHCLTech to acquire German e-mobility tech provider for about Rs 2,300 crJune 30, 2023 | bizjournals.comDonaldson Co. acquires Univercells Technologies, maker of biomanufacturing techJune 15, 2023 | seekingalpha.comSMAPU SportsMap Tech Acquisition Corp. UnitsMay 24, 2023 | businesswire.comIntelligent Medical Objects Announces the Acquisition of Melax Technologies Inc.May 19, 2023 | bizjournals.comLux Living sues KC developer over sale of Crossroads apartment siteMay 3, 2023 | bizjournals.comLux Living mixed-use skyscraper in downtown Kansas City advancesApril 26, 2023 | finance.yahoo.comBIMINI HEALTH TECH ACQUIRES EXCLUSIVE LICENSE TO ACELLULAR DERMAL MATRIX PRODUCT PORTFOLIOApril 9, 2023 | thestreet.comHotRail Climbs Aboard the Tech Acquisition Express TrainMarch 23, 2023 | bizjournals.comLouisville Health Care NewsMarch 7, 2023 | msn.comBest Buy announces partnership with Atrium Health to provide home healthcareMarch 1, 2023 | benzinga.comNew Health Tech Startup Automates Data Compliance to Unlock Insights and Bring Speed to the Healthcare IndustryFebruary 23, 2023 | health.usnews.comStephanie C. LuxFebruary 22, 2023 | technews.tmcnet.comCareCloud to Showcase How They Empower Healthcare Providers with Comprehensive Technology Solutions at AAOS Annual MeetingFebruary 2, 2023 | axios.comDigital health hit five-year funding low last yearJanuary 10, 2023 | msn.comHarvard senior fellow Mashall Lux calls buy now, pay later 'financial dynamite'January 10, 2023 | bizjournals.comSanta Clara software provider LeanTaaS is now valued at more than $1B after an acquisitionSee More Headlines Receive LUXA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lux Health Tech Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/03/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorUnclassified Industry Holding & other investment offices Sub-IndustryN/A Current SymbolNASDAQ:LUXA CUSIPN/A CIK1823767 Webwww.luxhealth.tech Phone646-475-4385FaxN/AEmployees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$27.10 million Net MarginsN/A Pretax MarginN/A Return on Equity-83.35% Return on Assets5.73% Debt Debt-to-Equity RatioN/A Current Ratio0.13 Quick Ratio0.13 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$0.63 per share Price / Cash Flow15.98 Book Value($0.64) per share Price / Book-15.69Miscellaneous Outstanding Shares43,125,000Free Float34,500,000Market Cap$432.98 million OptionableNot Optionable Beta-0.08 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Joshua Defonzo (Age 41)CEO & Director Ms. Segolene Scarborough (Age 42)CFO & Treasurer Key CompetitorsNabors Energy Transition Corp. IINASDAQ:NETDRigel Resource AcquisitionNYSE:RRACInflection Point Acquisition Corp. IINASDAQ:IPXXKismet Acquisition TwoNASDAQ:KAIICC Neuberger Principal Holdings IINYSE:PRPBView All Competitors This page (NASDAQ:LUXA) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldUrgent Nvidia WarningAltimetryAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldGold ManiaStansberry ResearchThe Gold Grab of the CenturyColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lux Health Tech Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
